Current Pharmacogenomics and Personalized Medicine
Title:Editorial (An Idea Whose Time Has Come? An African Foresight Observatory on Genomics Medicine and Data-Intensive Global Science)
Volume: 10 Issue: 1
Author(s): Collet Dandara, Clement Adebamowo, Jantina de Vries, Edward S. Dove, Erik Fisher, Richard A. Gibbs, Peter J. Hotez, Ilona Kickbusch, Bartha M. Knoppers, Mario Masellis, Mikkel Z. Oestergaard, Tikki Pang and Charles N. Rotimi
Affiliation:
Keywords: Africa, genomics and biobanks 101, global health diplomacy and public health pharmacogenomics, global personalized medicine, neglected tropical diseases, socio-technical integration research (STIR), vaccinomics and personalized vaccines, West African Bioethics Training Program
Export Options
About this article
Cite this article as:
Dandara Collet, Adebamowo Clement, de Vries Jantina, S. Dove Edward, Fisher Erik, A. Gibbs Richard, J. Hotez Peter, Kickbusch Ilona, M. Knoppers Bartha, Masellis Mario, Z. Oestergaard Mikkel, Pang Tikki and N. Rotimi Charles, Editorial (An Idea Whose Time Has Come? An African Foresight Observatory on Genomics Medicine and Data-Intensive Global Science), Current Pharmacogenomics and Personalized Medicine 2012; 10 (1) . https://dx.doi.org/10.2174/1875692111201010007
DOI https://dx.doi.org/10.2174/1875692111201010007 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vascular Risk Factors and Alzheimer’s Disease Pathogenesis: Are Conventional Pharmacological Approaches Protective For Cognitive Decline Progression?
CNS & Neurological Disorders - Drug Targets Prematurely Aged Children: Molecular Alterations Leading to Hutchinson-Gilford Progeria and Werner Syndromes
Current Aging Science Hypertension in the Elderly: An Evidence-based Review
Current Pharmaceutical Design Kinetics of In Vitro Inhibition of Acetylcholinesterase by Nineteen New Carbamates
Current Enzyme Inhibition The Axis of Thrombospondin-1, Transforming Growth Factor Beta and Connective Tissue Growth Factor: An Emerging Therapeutic Target in Rheumatoid Arthritis
Current Vascular Pharmacology Application of Sulfamic Acid in Organic Synthesis-A Short Review
Current Organic Chemistry Pharmaceutical Interventions for Frailty and Sarcopenia
Current Pharmaceutical Design Assessment of Acute Coronary Syndromes: Focus on Novel Biomarkers
Current Medicinal Chemistry Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
Current Neuropharmacology Fighting Alzheimer's Disease and Type 2 Diabetes: Pathological links and Treatment Strategies
CNS & Neurological Disorders - Drug Targets Key Role of Mitochondria in Alzheimer’s Disease Synaptic Dysfunction
Current Pharmaceutical Design Therapeutic Application of Intrabodies Against Age-Related Neurodegenerative Disorders
Current Pharmaceutical Design Relationships Between White Matter Hyperintensities, Cerebral Amyloid Angiopathy and Dementia in a Population-based Sample of the Oldest Old
Current Alzheimer Research Carotid Artery Disease: Current Concepts on Endothelial Dysfunction and Matrix Remodeling
Current Drug Therapy Development of Small-Molecule Inhibitors of Raf
Recent Patents on Anti-Infective Drug Discovery Frontotemporal Lobar Degeneration (FTLD): Review and Update for Clinical Neurologists
Current Alzheimer Research Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease
Current Topics in Medicinal Chemistry Immunological Therapeutic and Imaging Approaches for Prion Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Moderate Hyperhomocysteinemia and Immune Activation
Current Pharmaceutical Biotechnology Kynurenine Pathway and Disease: An Overview
CNS & Neurological Disorders - Drug Targets